Abstract DNA helix rising toward a horizon of light
Strategic Advisory · Biotech & Biopharma

Every breakthrough begins with a Prolog.

We are a strategic advisory firm for biotech and biopharma — bringing the counsel, connections, and business development expertise that turn hard-won science into the next chapter of impact.

“Whatever has been learned and achieved before is not the end of the story — it is the prologue to the next big thing to come.” Our founding conviction

A name that means what comes next.

In literature, the prologue introduces the story that follows. In science, it is the same: every discovery, every dataset, every hard-earned milestone is not a conclusion — it is the introduction to something bigger.

Prolog was founded to be that introduction. We connect the promise of your science with the partners, capital, and strategy it needs — so that everything you have achieved so far becomes the opening chapter of your next breakthrough.

We are a new firm with a simple posture: deep respect for the work behind you, and clear eyes on the road ahead.

Three ways we open doors.

From first strategy to signed deal, we work as an embedded partner — not a distant consultant.

Chapter I

Strategic Advisory

Clear-eyed strategic counsel for founders and leadership teams navigating inflection points — from asset positioning to corporate strategy.

  • Asset & platform positioning
  • Indication prioritization & development strategy
  • Corporate strategy and milestone planning
  • Board- and investor-ready narrative development
Chapter II

Connections

An intentional introduction is worth a thousand cold emails. We open the right doors across the biotech and biopharma ecosystem.

  • Curated introductions to pharma partners
  • KOL, advisor & clinical network building
  • Investor and strategic capital introductions
  • CRO / CDMO and vendor ecosystem access
Chapter III

Business Development

Hands-on BD execution — from first conversation to term sheet — grounded in deep knowledge of how deals actually get done.

  • Partnership & licensing strategy
  • Outreach, meeting preparation & negotiation support
  • Due diligence management
  • Deal structuring and term-sheet counsel

Built for the builders of biology.

Biotech

Emerging biotech

Seed-to-clinical-stage companies with promising science and a full plate. We act as your extended BD and strategy function — positioning your assets, building your network, and running partnership processes so your team can stay focused on the pipeline.

Biopharma

Established biopharma

For pharma and scaled biotech, we provide external-innovation origination: scanning the ecosystem for the modalities, platforms, and teams worth meeting — and shepherding in-licensing and collaboration conversations from introduction to execution.

Abstract network of connected nodes in gold and teal

The right introduction can change everything.

Deals don't happen between companies — they happen between people. Our network across biotech, pharma, and investment communities is the connective tissue of everything we do.

Meet the Network
“The best endings are rarely endings at all — they are beginnings, dressed in the language of conclusion.”
— The spirit of every engagement

Ready to begin your next chapter?

Tell us where your science stands and where you want it to go. We'll bring the strategy, the introductions, and the BD muscle to help you get there.

contact@prolog-bio.com​
Confidential conversations, always. · Typically responding within two business days